PeerVoice Oncology & Haematology Audio

PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.

http://www.peervoice.com

Eine durchschnittliche Folge dieses Podcasts dauert 20m. Bisher sind 324 Folge(n) erschienen. Dies ist ein wöchentlich erscheinender Podcast.

Gesamtlänge aller Episoden: 5 days 19 hours 51 minutes

subscribe
share






share








 September 22, 2015  15m
 
 

Utilizing Patient and Drug Characteristics To Optimize Kinase Inhibitor Therapy in Relapsed/Refractory CLL


Go online to www.peervoice.com/h/pvr196 to view the entire programme with slides.


share








 September 2, 2015  15m
 
 

Optimizing Management of Patients With Advanced NSCLC: Insights and Strategies for Managing Tolerability


Go online to www.peervoice.com/h/pvr203 to view the entire programme with slides.


share








 August 31, 2015  14m
 
 

Second-Line Treatments for Advanced NSCLC: Putting the Data Into Perspective


Second-Line Treatments for Advanced NSCLC: Putting the Data Into Perspective


share








 August 28, 2015  20m
 
 

Evaluating the Evidence: Is There a Role for Non-Platinum Agents in Recurrent Ovarian Cancer?


Go online to www.peervoice.com/h/pvr225 to view the entire programme with slides.


share








 August 17, 2015  12m
 
 

Second-Line Treatment of Adenocarcinoma: A Look at New and Future Targeted Treatment Options


Go online to www.peervoice.com/h/pvr201 to view the entire programme with slides.


share








 August 14, 2015  16m
 
 

The Role of Molecular Monitoring for CML: Getting the Expert’s Take


The Role of Molecular Monitoring for CML: Getting the Expert’s Take


share








 July 24, 2015  10m
 
 

Individualizing Treatment Choices for Metastatic Melanoma: Which Therapy Is Best for Which Patient?


Go online to www.peervoice.com/h/pvr197 to view the entire programme with slides.


share








 July 22, 2015  18m
 
 

Fine-Tuning Management of Advanced NSCLC: Clinical Implications of EGFR Mutations and Histology


Go online to www.peervoice.com/h/pve72 to view the entire programme with slides.


share








 July 10, 2015  1h5m
 
 

The Evolving Treatment Landscape in Gastric Cancer: How Will Targeted Therapy Affect Clinical Practice?


Go online to www.peervoice.com/h/pve65 to view the entire programme with slides.


share








 July 8, 2015  30m